Á¦ ¸ñ 2023³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2023-06-20
÷ ºÎ ÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù. Á¶ ȸ 1698
<style><!--
.award-conts-200622 * {
box-sizing: border-box;

}

.award-conts-200622 {
max-width: 1118px;
margin: 0 auto;

}

.award-conts-200622 .main-tit {
text-align: center;
margin: 55px 0;
font-size: 30px;
font-weight: bold;
line-height: 1.6;
}



.award-conts-200622 .tit {
margin: 30px 0 0 0;
font-weight: bold;
font-size: 17px;
}

.award-conts-200622 .tit-under-txt {
padding: 0 0 0 23px;
font-size: 14px;
}

.award-conts-200622 .sub-tit {
padding: 10px 0 0 17px;
font-size: 15px;
}

.award-conts-200622 .notice-award-table {
border-collapse: collapse;
width: 100%;
min-width: 700px;
border-top: solid 2px #68a9eb;
margin: 10px 0 0 0px;
}

.award-conts-200622 .notice-award-table.other-with {
width: 50%;
min-width: 501px;
}

.award-conts-200622 .notice-award-table td,
.award-conts-200622 .notice-award-table th {
padding: 7px;
border: solid 1px #cccccc;
font-size: 14px;
word-break: keep-all;
text-align: center;
vertical-align: middle;

}

.award-conts-200622 .notice-award-table .txt-left {
text-align: left;
}

.award-conts-200622 .notice-award-table th {
background-color: #f9f9f9;
}
--></style>
<div class="award-conts-200622">
<div class="main-tit">2023³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ ¸í´Ü</div>
<div class="tit">1. Á¦ 15ȸ ´ëÇѾÏÇÐȸ ¿ì¼ö³í¹®»ó (CRTÀú³Î¿¡ °ÔÀçµÈ ³í¹® Áß ±âÃÊ 2Æí, ÀÓ»ó ¹× Áß°³ 5Æí, »ó±Ý °¢ 200¸¸¿ø)</div>
<div class="tit">1) ±âÃʺоß</div>
<table class="notice-award-table"><colgroup> <col style="width: 5%;" /> <col style="width: 5%;" /> <col style="width: 20%;" /> <col style="width: 40%;" /> <!-- <col style="width: 8%;" /> --> </colgroup>
<tbody>
<tr><th width="6%">No.</th><th width="8%">ºÐ¾ß</th><th width="15%">Ã¥ÀÓÀúÀÚ/ 1ÀúÀÚ </th><th width="71%">³í¹®Á¦¸ñ</th><!-- <th>ÆäÀÌÁö¹øÈ£</th> --></tr>
<tr>
<td rowspan="2" width="38">1</td>
<td rowspan="2" width="51">±âÃÊ</td>
<td width="292">¼­¿ïÀÇ´ë ¿Àµµ¿¬</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.473" target="_blank">Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer</a></td>
</tr>
<tr>
<td width="292">¼­¿ïÀÇ´ë ¼­Çý¸²</td>
</tr>
<tr>
<td rowspan="2">2</td>
<td rowspan="2">±âÃÊ</td>
<td width="292">°¡Å縯ÀÇ´ë ±è¼¼ÁØ</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2020.1063" target="_blank">Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells</a></td>
</tr>
<tr>
<td width="292">°¡Å縯ÀÇ´ë Àü¿¹¿ø</td>
</tr>
</tbody>
</table>
<div class="tit">2) ÀÓ»ó ¹× Áß°³ ºÐ¾ß</div>
<table class="notice-award-table"><colgroup> <col style="width: 5%;" /> <col style="width: 5%;" /> <col style="width: 20%;" /> <col style="width: 40%;" /> <!-- <col style="width: 8%;" /> --> </colgroup>
<tbody>
<tr><th>No.</th><th>ºÐ¾ß</th><th>Ã¥ÀÓÀúÀÚ/ 1ÀúÀÚ</th><th>³í¹®Á¦¸ñ</th><!-- <th>ÆäÀÌÁö¹øÈ£</th> --></tr>
<tr>
<td rowspan="2" width="38">1</td>
<td rowspan="2" width="51">ÀÓ»ó</td>
<td width="292">¼­¿ï¾Æ»êº´¿ø Á¤¼®ÈÆ<br /> ¼­¿ï¾Æ»êº´¿ø ¼­¼¼¿µ</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.585" target="_blank">Functional Impairments in the Mental Health, Depression and Anxiety Related to the Viral Epidemic, and Disruption in Healthcare Service Utilization among Cancer Patients in the COVID-19 Pandemic Era</a></td>
</tr>
<tr>
<td width="292">¼­¿ï¾Æ»êº´¿ø ±è±Ô¹Î</td>
</tr>
<tr>
<td rowspan="2">2</td>
<td rowspan="2">ÀÓ»ó</td>
<td width="292">¼­¿ïÀÇ´ë ±èÀÏÇÑ</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.142" target="_blank">The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11)</a></td>
</tr>
<tr>
<td width="292">¼­¿ïÀÇ´ë ÀÌÁÖÈ£</td>
</tr>
<tr>
<td rowspan="2">3</td>
<td rowspan="2">ÀÓ»ó</td>
<td width="292">¼­¿ï¾Æ»êº´¿ø ¹Ú¼÷·Ã</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2020.1198" target="_blank">Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors</a></td>
</tr>
<tr>
<td width="292">°í·ÁÀÇ´ë ±èÁÂÈÆ</td>
</tr>
<tr>
<td rowspan="2">4</td>
<td rowspan="2">ÀÓ»ó</td>
<td width="292">»ï¼º¼­¿ïº´¿ø ÀÌÀ¯¿µ<br /> »ï¼º¼­¿ïº´¿ø ¹Ú¿ø</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.023" target="_blank">Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival</a></td>
</tr>
<tr>
<td width="292">»ï¼º¼­¿ïº´¿ø ³ë°æ¿ø</td>
</tr>
<tr>
<td rowspan="2">5</td>
<td rowspan="2">Áß°³</td>
<td width="292">¿¬¼¼ÀÇ´ë ÀåÁö¼®<br /> ¿¬¼¼ÀÇ´ë ¾ÈÁß¹è</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2020.1247" target="_blank">Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations</a></td>
</tr>
<tr>
<td width="292">¿¬¼¼ÀÇ´ë ±è°æȯ<br /> ¿¬¼¼ÀÇ´ë ±èÇÑ»ó</td>
</tr>
</tbody>
</table>
<div class="tit">2. Á¦ 13ȸ ¸ÓÅ© ¾ÏÇмú»ó (CRT¿¡ °ÔÀçµÈ ÀÓ»ó³í¹® Áß ´ëÀå¾Ï, µÎ°æºÎ, Æó¾Ï, ¹æ±¤¾Ï ³í¹®, »ó±Ý °¢ 200¸¸¿ø)</div>
<table class="notice-award-table"><colgroup> <col style="width: 5%;" /> <col style="width: 15%;" /> <col style="width: 45%;" /> <!-- <col style="width: 8%;" /> --> </colgroup>
<tbody>
<tr><th>No.</th><th>Ã¥ÀÓÀúÀÚ/ 1ÀúÀÚ</th><th>³í¹®Á¦¸ñ</th><!-- <th>ÆäÀÌÁö¹øÈ£</th> --></tr>
<tr>
<td rowspan="2" width="38">1</td>
<td width="51">¼­¿ï¾Æ»êº´¿ø ±è¼±¿µ<br /> ¼­¿ï¾Æ»êº´¿ø ¼ºÃ¢¿Á</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.1133" target="_blank">Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability–High Colon Cancer</a></td>
</tr>
<tr>
<td width="51">¼­¿ï¾Æ»êº´¿ø ÇüÀç¿ø<br /> ¾Æ»ê»ý¸í°úÇבּ¸¿ø Á¶ÀºÁ¤</td>
</tr>
<tr>
<td rowspan="2">2</td>
<td width="51">¼­¿ïÀÇ´ë Á¤Ã¢¿í</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.642" target="_blank">Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis</a></td>
</tr>
<tr>
<td width="51">¼­¿ïÀÇ´ë ¼­Á¤±³<br /> ¼­¿ï´ë »ý¹°ÀÇÇבּ¸¼Ò ÇѵµÇö</td>
</tr>
<tr>
<td rowspan="2">3</td>
<td width="51">»ï¼º¼­¿ïº´¿ø ¹Ú¼¼ÈÆ<br /> »ï¼º¼­¿ïº´¿ø Á¤º´Ã¢</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.854" target="_blank">Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy</a></td>
</tr>
<tr>
<td width="51">»ï¼º¼­¿ïº´¿ø ±è·ü<br /> »ï¼º¼­¿ïº´¿ø È«Á¤¿ë</td>
</tr>
<tr>
<td rowspan="2">4</td>
<td width="51">¼­¿ï¾Æ»êº´¿ø ÀÌ´ëÈ£<br /> ¼­¿ï¾Æ»êº´¿ø ¹Ú°­¼­</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2021.651" target="_blank">Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non–Small Cell Lung Cancer</a></td>
</tr>
<tr>
<td width="51">¼­¿ï¾Æ»êº´¿ø À±½Å±³</td>
</tr>
<tr>
<td rowspan="2">5</td>
<td width="51">¼­¿ïÀÇ´ë ±è¹ü¼®</td>
<td class="txt-left" rowspan="2"><a href="https://doi.org/10.4143/crt.2020.1329" target="_blank">Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)</a></td>
</tr>
<tr>
<td width="51">¼º±Õ°üÀÇ´ë ÀÌÀ±±Ô<br /> °í·ÁÀÇ´ë °­ÀºÁÖ</td>
</tr>
</tbody>
</table>
<div class="tit">3. Á¦ 12ȸ ±¤µ¿¾ÏÇмú»ó</div>
<div class="sub-tit">1) ÃÖ°í IF SCI ÇмúÁö¿¡ ³í¹®À» ¹ßÇ¥ÇÑ ±âÃÊ ¹× ÀÓ»ó ºÐ¾ßÀÇ Ã¥ÀÓÀúÀÚ °¢ 1¸í</div>
<table class="notice-award-table"><colgroup> <col style="width: 5%;" /> <col style="width: 5%;" /> <col style="width: 15%;" /> <col style="width: 23%;" /> <col style="width: 8%;" /> </colgroup>
<tbody>
<tr><th>No</th><th>ºÐ¾ß</th><th>Ã¥ÀÓÀúÀÚ</th><th>³í¹®Á¦¸ñ</th><th>°ÔÀçÇмúÁö</th></tr>
<tr>
<td rowspan="2" width="38">1</td>
<td rowspan="2" width="51">±âÃÊ</td>
<td width="292">¿¬¼¼ÀÇ´ë À̽ÂÅÂ</td>
<td class="txt-left" rowspan="2"><a href="http://dx.doi.org/10.1093/clinchem/hvac146" target="_blank">Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden</a></td>
<td rowspan="2" width="149">Clin Chem.<br /> 2022;68(12):1519-28</td>
</tr>
<tr>
<td width="292">¿¬¼¼ÀÇ´ë ¶ó¼±¿µ</td>
</tr>
<tr>
<td rowspan="2" width="38">2</td>
<td rowspan="2" width="51">ÀÓ»ó</td>
<td width="292">¼­¿ï¾Æ»êº´¿ø Á¤°æÇØ</td>
<td class="txt-left" rowspan="2"><a href="http://dx.doi.org/10.1001/jamaoncol.2022.2310" target="_blank">Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer The Neo-PATH Phase 2 Nonrandomized Clinical Trial</a></td>
<td rowspan="2" width="149">JAMA Oncol. <br /> 2022;8(9):1271-7</td>
</tr>
<tr>
<td width="292">»ï¼º¼­¿ïº´¿ø ¹Ú¿¬Èñ</td>
</tr>
</tbody>
</table>
<div class="sub-tit">2) ´Ù¼öÀÇ SCI µîÀç ÇмúÁö¿¡ ³í¹®À» ¹ßÇ¥ÇÑ Ã¥ÀÓ ÀúÀÚ 1¸í</div>
<table class="notice-award-table"><colgroup> <col style="width: 5%;" /> <col style="width: 6%;" /> <col style="width: 15%;" /> <col style="width: 25%;" /> <col style="width: 8%;" /> </colgroup>
<tbody>
<tr><th>No</th><th>ºÐ¾ß</th><th>Ã¥ÀÓÀúÀÚ</th><th>³í¹®Á¦¸ñ</th><th>°ÔÀçÇмúÁö</th></tr>
<tr>
<td width="38">1</td>
<td width="51">´Ù¼ö ¹ßÇ¥</td>
<td width="292">ÇѾçÀÇ´ë ¹Úº¸¿µ</td>
<td class="txt-left" rowspan="2"><a href="http://dx.doi.org/10.14309/ajg.0000000000001837" target="_blank">Association Between Family History of Gastric Cancer and the Risk of Gastric Cancer and Adenoma: A Nationwide Population-Based Study ¿Ü 7Æí</a></td>
<td width="149">Am J Gastroenterol.<br /> 2022;117(8)1255-63</td>
</tr>
</tbody>
</table>
<div class="tit">4. Á¦15ȸ ´ëÇѾÏÇÐȸÁö Best Reviewer»ó (4¸í ¼±Á¤, »ó±Ý °¢ 100¸¸¿ø)</div>
<div class="tit-under-txt">: ÃÖ±Ù 2³â°£, 2021³â 1¿ù ~ 2022³â 12¿ù±îÁö ½É»çÇÑ À§¿øÀ¸·Î ½É»ç±â°£À» ÁؼöÇÏ°í, ½É»çÀÇ °´°ü¼º, Ÿ´ç¼º, °Ç¼³ÀûÀÎ ÀÇ°ßÀ¸·Î ³í¹®ÀÇ ÁúÀû Çâ»ó¿¡ ±â¿©ÇÑ ½É»çÀ§¿ø ¼±Á¤</div>
<table class="notice-award-table other-with"><colgroup> <col style="width: 50%;" /> <col style="width: 50%;" /> </colgroup>
<tbody>
<tr><th colspan="2">¼ö»óÀÚ</th></tr>
<tr>
<td>±¸µ¿È¸(¼º±Õ°üÀÇ´ë ³»°ú)</td>
<td>½ÉÈ¿¼·(¿¬¼¼ÀÇ´ë º´¸®°ú)</td>
</tr>
<tr>
<td>ÀåÁö¼®(¿¬¼¼ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)</td>
<td>ÀÌÀº»ó(°í·ÁÀÇ´ë ¼Ò¾ÆÇ÷Á¾³»°ú)</td>
</tr>
</tbody>
</table>
</div>